STOCK TITAN

Xebra Brands Stock Price, News & Analysis

XBRAF OTC

Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.

Xebra Brands Ltd. (XBRAF) generates frequent corporate and regulatory updates that are relevant for investors following cannabis and wellness companies. Its news flow covers both operational developments and capital markets events across its activities in Mexico, Canada and the United States.

In its releases, Xebra reports on the development and commercialization of cannabis‑derived wellness products, including its ELEMENTS™ CBD product line and Vicious Citrus THC/CBN lemonades. News items have described progress toward the U.S. launch of ELEMENTS™, such as finalized product formulations, packaging and e‑commerce planning, as well as integration into logistics and fulfillment infrastructure.

The company’s disclosures also address regulatory milestones and authorizations. Xebra highlights its authorization from COFEPRIS in Mexico to import, cultivate, manufacture and sell cannabis with less than 1% THC, and provides updates on how this supports its international cannabis cultivation and product strategy.

From a capital markets perspective, Xebra’s news includes information on management changes, loan agreements with existing shareholders, warrant expiry extensions, and share consolidation plans on a ten‑for‑one basis. The company has also issued detailed updates on its management cease trade order and subsequent failure‑to‑file cease trade order related to delayed financial statement filings, as well as the impact on trading of its securities on the Canadian Securities Exchange and its move from the OTCQB Market to the OTC Pink Open Market.

Readers of the XBRAF news page can expect coverage of product commercialization efforts, regulatory authorizations, financing and corporate structure changes, and filing status reports. Monitoring these releases can help track how Xebra manages its cannabis‑derived product portfolio, regulatory relationships and listing status over time.

Rhea-AI Summary

Xebra Brands has achieved a significant milestone by executing its first purchase order of CBD products from Restorative Botanicals.

The order covers 2,500 units of 250mg Tangerine Flavor CBD Tincture, authorized for import, launch, and sale in Mexico by COFEPRIS.

This product will be used in sample packages sent to retailers as part of the listing process, expanding Xebra's footprint in the Mexican cannabis market.

This step underscores the strategic partnership between Xebra and Restorative Botanicals, aimed at delivering high-quality CBD products.

Interim-CEO Rodrigo Gallardo emphasized this as a important step for Xebra in providing legally recognized CBD products in Mexico.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.36%
Tags
none
-
Rhea-AI Summary

Xebra Brands has expressed its congratulations to President-Elect Claudia Sheinbaum on her recent election victory, marking her as Mexico's first female president. Xebra is optimistic about Sheinbaum's commitment to cannabis reform, aligning with the company's vision for a regulated and inclusive cannabis industry. Sheinbaum advocates for decriminalizing recreational cannabis use, focusing on education and public health over punitive measures. Xebra's CEO, Rodrigo Gallardo, highlighted the potential social justice and violence reduction benefits from responsible cannabis regulation. The company plans to collaborate with Sheinbaum's administration and Mexico's Cofepris to ensure safe, regulated cannabis products are accessible. Xebra is prepared to invest and innovate under Mexico's leadership to help the country become a global leader in the cannabis sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.67%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.47%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.77%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.89%
Tags
partnership
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
38.87%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
49.8%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Xebra Brands (XBRAF)?

The current stock price of Xebra Brands (XBRAF) is $0.007 as of February 9, 2026.

What is the market cap of Xebra Brands (XBRAF)?

The market cap of Xebra Brands (XBRAF) is approximately 179.6K.

XBRAF Rankings

XBRAF Stock Data

179.65k
6.88M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver

XBRAF RSS Feed